----

| 1. | Employment. |
|----|-------------|

|  | 1.1. | Executive shall serve in the position described in Exhibit A commencing on the date indicated in that exhibit (the “Commencement Date”). Executive shall be under the direct supervision of the Chief Executive Officer of BioLine or any individual designated by BioLine at its sole discretion (the “Supervisor”). Executive shall perform the duties, undertake the responsibilities and exercise the authority as determined from time to time by the Supervisor diligently, conscientiously and in furtherance of BioLine’s best interests. Executive’s duties and responsibilities hereunder may also include other services performed for affiliates of BioLine. |
|--|------|--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

|  | 1.2. | During the Employment Period (as defined in Section 5), Executive shall honestly, diligently, skillfully and faithfully serve BioLine, and undertakes to devote all of Executive’s efforts and the best of her qualifications and skills to promoting the business and affairs of BioLine, and shall at all times act in a manner suitable of her position and status in BioLine. |
|--|------|-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

|  | 1.3. | Executive agrees and undertakes to inform BioLine, immediately after becoming aware of any matter that may in any way raise a conflict of interest between Executive and BioLine. Executive shall not receive any payment, compensation or benefit from any third party in connection, directly or indirectly, with the execution of Executive’s position in BioLine. |
|--|------|-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

|  | 1.4. | Executive will be employed on a full time basis. Executive shall not undertake or accept any other paid or unpaid employment or occupation or engage in any other business activity except with the prior written consent of BioLine, which shall not be unreasonably withheld. |
|--|------|---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

|  | 1.5. | Executive hereby confirms and declares that her position is one that requires a special measure of personal trust and loyalty. Accordingly, the provisions of the Hours of Work and Rest Law, 1951 shall not apply to Executive, and Executive shall not be entitled to any compensation for working more than the maximum number of hours per week set forth in said law or any other applicable law. |
|--|------|--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

|  | 1.6. | Executive may also work outside of regular working hours and outside of regular working days, as may be required by BioLine from time to time. |
|--|------|------------------------------------------------------------------------------------------------------------------------------------------------|

|  | 1.7. | The parties hereby confirm that this is an agreement for personal services and that the relationship between the parties shall not be subject to any general or special collective employment agreement or any custom or practice of BioLine with respect to any of its other employees or contractors. |
|--|------|---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

|  | 1.8. | Executive acknowledges that the validity of this Agreement is conditioned on its approval by the Compensation Committee and Board of Directors of BioLine and that in the absence of such approvals, this Agreement is null and void. BioLine will inform Executive promptly after the decision of the Board of Directors has been made. |
|--|------|------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

| 2. | Place of Performance. Executive shall be based at BioLine’s facilities in Modi’in. In addition, Executive may be required to perform work at such other places as are appropriate to the functions being performed by BioLine. Executive acknowledges and agrees that her position may involve significant domestic and international travel. |
|----|-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

----

| 3. | Executive’s Representations and Warranties. Executive represents and warrants that the execution and delivery of this Agreement and the fulfillment of all its terms: (i) will not constitute a default under or conflict with any agreement or other instrument to which Executive is a party or by which Executive is bound; and (ii) do not require the consent of any person or entity. Further, with respect to any past engagement Executive may have had with third parties and with respect to any allowed engagement Executive may have with any third party during the term of her engagement with BioLine (for purposes hereof, such third parties shall be referred to as “Other Employers”), Executive represents, warrants and undertakes that: (a) Executive’s engagement with BioLine is and will not be in breach of Executive’s undertakings towards Other Employers, and (b) Executive will not disclose to BioLine, or use, in provision of any services to BioLine, any proprietary or confidential information belonging to any Other Employers. Executive further represents and warrants that: (y) she does not suffer from any medical condition that may prevent from complying with duties and obligations under this Agreement; and (z) to Executive’s best knowledge, the employment by BioLine will not cause any hazard to Executive’s health. |
|----|-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

| 4. | Proprietary Information; Confidentiality and Non-Competition. By executing this Agreement, Executive agrees to the provisions of BioLine’s Proprietary Information, Confidentiality and Non-Competition Agreement attached as Exhibit B hereto. The terms of Executive’s employment are personal and confidential, and Executive undertakes to refrain from disclosing such terms to any third party, other than her consultants, immediate family or as otherwise required by Israeli, United States and California law or injunction. |
|----|----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

| 5. | Period of Employment. Executive’s employment by BioLine commences on the Commencement Date and shall then continue, unless terminated in accordance with the provisions of this Agreement. The time during which Executive shall be employed by BioLine shall be referred to as the “Employment Period”. |
|----|----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

|  | 5.1. | Death or Disability. Executive’s employment will terminate upon the death of the Executive, and BioLine may terminate Executive’s employment after having established Executive’s disability. For purposes of this Agreement, “disability” means a physical or mental infirmity which impairs Executive’s ability to substantially perform Executive’s duties under this Agreement which continues for a period of at least ninety (90) consecutive days. Upon termination for disability, Executive shall be entitled to severance pay required by law, in accordance with the terms of this Agreement. |
|--|------|----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

|  | 5.2. | Termination at Will. Either party may terminate the employment relationship hereunder at any time by giving the other party prior written notice, as set forth in Exhibit A (the “Notice Period”). |
|--|------|---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

|  | 5.3. | Termination for Cause. In the event of a termination for Cause (as defined below), BioLine may immediately terminate the employment relationship effective as of the time of notice of the same, and without payment in lieu of prior notice. “Cause” means (i) a material breach of trust including but not limited to theft, embezzlement, self-dealing, prohibited disclosure to unauthorized persons or entities of confidential or proprietary information of or relating to BioLine or its affiliates, unless required by law or injunction, and the engaging by Executive in any prohibited business competitive to the business of BioLine; (ii) any willful failure to perform or failure to perform competently any of Executive’s fundamental functions or duties hereunder, which was not cured within thirty (30) days after receipt by Executive of written notice thereof; (iii) any breach of this Agreement by Executive; and (iv) any other cause justifying termination or dismissal without severance payment under applicable law. |
|--|------|---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

|  | 5.4. | Notice Period; End of Relations. During the Notice Period, the employment relationship hereunder shall remain in full force and effect and there shall be no change in Executive’s position with BioLine, the Salary, social benefits or in any other obligations of either party hereunder. At the option of BioLine, Executive shall during such period either continue with Executive’s duties or remain absent from BioLine’s premises. However, BioLine, at its own discretion, may terminate this Agreement and the employment relationship at any time immediately upon a written notice and pay Executive an amount equal to the Salary referred to in Section 6 below including any and all social benefits that would have been paid to Executive during the Notice Period in lieu of the prior notice. In any event of the termination of this Agreement, Executive shall (a) immediately return all company property, equipment, materials and documents and (b) cooperate with BioLine and use Executive’s best efforts to assist with the integration into BioLine’s organization of the person or persons who will assume the Executive’s responsibilities.  Under no circumstances will Executive have a lien over any property provided by or belonging to BioLine. |
|--|------|-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

----

|  | 5.5. | Without derogating from all of BioLine’s rights according to the provisions of this Agreement and the law, upon the termination of this Agreement, BioLine shall have the right to deduct from any payment to be paid to Executive any sum owed by Executive to BioLine by a written document. |
|--|------|------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

| 6. | Salary. |
|----|---------|

|  | 6.1. | BioLine shall pay or cause to be paid to Executive during the term of this Agreement a gross monthly salary in the amount set forth in Exhibit A per month (the “Base Salary”). |
|--|------|---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

|  | 6.2. | The Salary will be paid no later than the ninth day of each calendar month after the month for which the Salary is paid, after deduction of any and all taxes and charges applicable to Executive, as may be in effect or which may hereafter be enacted or required by law. Executive shall notify BioLine of any change which may affect Executive’s tax liability. |
|--|------|-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

| 7. | Insurance and Social Benefits. |
|----|--------------------------------|

|  | 7.1. | Manager’s Insurance/Pension Fund. During the Employment Period, BioLine will insure Executive under a “Manager’s Insurance Scheme” or pension fund as agreed to by the parties (collectively the “Policy”). In the case of a Manager’s Insurance Scheme, BioLine will transfer to the Policy an amount equal to 6.5% for pension payments and disability insurance and 8.33% for severance compensation. If the cost of disability insurance is more than 1.5% of the Salary, the abovementioned 6.5% payment will be increased to a maximum of 7.5% of the Salary. In addition, BioLine shall deduct from the Salary an amount equal to 6% of the Salary and transfer the same to the Policy. In the case of a pension fund, BioLine will transfer an amount equal to 14.833% of the Salary to such Policy, of which 6.5% shall be for pension fund payments and 8.33% shall be for severance compensation, and in addition, BioLine shall deduct from the Salary an amount equal to 6% of the Salary and transfer the same to the Policy. Any tax payable in respect of such contributions to the Policy shall be borne and paid by Executive. The percentages listed above will be subject to adjustment in accordance with changes in applicable law from time to time. |
|--|------|-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

|  | 7.2. | Executive hereby agrees and acknowledges that all of the payments that BioLine shall make to the abovementioned Policy shall be instead of any severance pay to which Executive or Executive’s successors shall be entitled to receive from BioLine with respect to the salary from which these payments were made and the period during which they were made, in accordance with Section 14 of the Severance Pay Law 5723-1963 (the “Law”). The parties hereby adopt the General Approval of the Minister of Labor and Welfare, published in the Official Publications Gazette No. 4659 on June 30, 1998, attached hereto as Exhibit C. BioLine hereby waives in advance any claim it has or may have to be refunded any of the payments made to the manager’s insurance policy, unless (i) Executive’s right to severance pay is invalidated by a court ruling on the basis of Sections 16 or 17 of the Law (and in such case only to the extent it is invalidated), or (ii) Executive withdrew funds from the manager’s insurance policy for reasons other than an “Entitling Event”. An “Entitling Event” means death, disability or retirement at the age of sixty (60) or more. |
|--|------|--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

----

|  | 7.3. | Advanced Study Fund. During the Employment Period, BioLine will maintain for the Executive an advanced study fund (Keren Hishtalmut) recognized by the Israeli Income Tax Authorities, such that BioLine and Executive shall contribute to such fund an amount equal to 7.5% of the Salary and 2.5% of the Salary, respectively. Any tax payable in respect of such contributions to such fund shall be borne and paid by Executive. All payments and contributions of BioLine with respect to these benefits shall be limited to the Salary and up to the highest amount recognized by the tax authorities. |
|--|------|--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

|  | 7.4. | Convalescence. During the Employment Period, Executive shall be entitled to receive convalescence allowance (Dmei Havra’a) pursuant to applicable law. |
|--|------|--------------------------------------------------------------------------------------------------------------------------------------------------------------|

|  | 7.5. | Sick Leave. Executive shall be entitled to be absent from work each year due to illness for the number of days allowed pursuant to the Sick Pay Law 5736 - 1976, and shall be entitled to fully paid sick leave upon presentation of appropriate medical documentation regarding said illness. Any amounts paid to Executive on account of the disability insurance indicated in subsection 8.3 will be on account of sick leave payment. |
|--|------|-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

|  | 7.6. | Vacation. During the Employment Period, Executive shall be entitled to vacation in the number of working days per year as set forth in Exhibit A, as adjusted in accordance with applicable law.  A “working day” shall mean Sunday to Thursday inclusive, and the use of said vacation days will be coordinated with BioLine. Executive shall be entitled to accumulation and redemption of vacation days in accordance with BioLine’s policies, which may be amended from time to time in BioLine’s sole discretion. |
|--|------|-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

|  | 7.7. | Mobile Phone; Computer. During the Employment Period, Executive shall be entitled to receive a mobile phone and a laptop computer. Executive shall use the mobile phone and computer (together hereinafter: the “Equipment”) in a standard and reasonable manner, and in accordance with BioLine’s policies. The Executive hereby agrees that any amount due by Executive to BioLine in connection with the Equipment (including, e.g., compensation for loss or damage of the Equipment) shall be deducted from Executive’s Salary. |
|--|------|--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

|  | 7.8. | Automobile. During the Employment Period, for purposes of performance of Executive’s duties and tasks, BioLine shall make available to Executive a company vehicle of a type to be chosen by BioLine in accordance with its policy which may be amended from time to time (the “Company Car”). Before delivery of the Company Car, Executive shall sign BioLine’s Vehicle Agreement, the form of which is attached hereto as Exhibit G. Executive shall use the Company Car in accordance with the Vehicle Agreement as well as with BioLine’s car policy then in effect. For the avoidance of doubt, Executive agrees that the cost of the leasing and the cost of the use of the Company Car shall not constitute a component of Executive’s Salary, including with regard to social benefits or any other right to which Executive is entitled by virtue of this Agreement or under law. |
|--|------|---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

| 8. | BioLine Property. Executive acknowledges and agrees that the Equipment, email account and any other device or system providing for transmittal and storage of information which are placed at Executive’s disposal by BioLine during the Employment Period are and shall remain the property of BioLine. Executive confirms her understanding that BioLine may review email correspondence and other information transmitted and stored by using the equipment stated above, and BioLine reserves the right to copy, store, present to others, and use such information. Executive acknowledges and agrees that any messages and data sent from, received by, or stored in or upon BioLine’s computers and communications systems are the sole property of BioLine, regardless of the form or content of these messages and data. Executive should not consider messages and data sent from, received by, or stored in or upon BioLine’s computer and communications systems to be private and should not send, receive, or store sensitive personal or private information using these systems. Executive is deemed to have consented, subject to any applicable law, to any reasonable use, transfer and disclosure of all messages and data contained or sent via the BioLine’s computer and communications systems, including electronic mail. Executive shall fully comply with BioLine’s policies regarding its computers and network, as may be in effect from time to time. |
|----|-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

----

| 9. | Expenses. Executive shall be reimbursed for all direct business expenses borne by Executive, in accordance with BioLine’s policies as determined by BioLine from time to time, provided that such expenses were approved by Executive’s Supervisor in advance. As a condition to reimbursement, Executive shall be required to provide BioLine with all invoices, receipts and other evidence of expenditures as may be reasonably required by BioLine from time to time. |
|----|---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

| 10. | Equity Compensation. Subject to the approval of the Board of Directors of BioLine and the execution of the requisite agreements, Executive shall be granted (a) options to purchase Ordinary Shares par value NIS 0.10 each of BioLine, in the amount set forth in Exhibit A, and (b) performance stock units in the amount set forth in Exhibit A, all to be granted pursuant to, and in accordance with, the terms and conditions of the share incentive plan adopted by BioLine. |
|-----|-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

| 11. | Code of Business Conduct and Ethics; Internal Policies. Executive shall at all times comply with the Code of Business Conduct and Ethics attached hereto as Exhibit D, the Policy regarding Securities Trades by Company Personnel attached hereto as Exhibit E, the Company’s Internal Enforcement Policy attached hereto as Exhibit F, and all other internal policies and procedures of BioLine, as shall be updated from time to time. Updates to Exhibits D, E and F, and copies of BioLine’s internal policies and procedures, can be obtained at BioLine’s human resources office. Executive represents that she has read Exhibits D, E and F, will acquaint herself with BioLine’s other internal policies and procedures and agrees to comply with their terms, including any amendments and updates thereto. |
|-----|------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

| 12. | General. |
|-----|----------|

|  | 12.1. | The laws of the State of Israel shall apply to this Agreement and the sole and exclusive place of jurisdiction in any matter arising out of or in connection with this Agreement shall be the Tel Aviv Regional Labor Court. The provisions of this Agreement are in lieu of the provisions of any collective bargaining agreement, and therefore, no collective bargaining agreement shall apply with respect to the relationship between the parties hereto (subject to the applicable provisions of law). |
|--|-------|--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

|  | 12.2. | This Agreement constitutes the entire agreement and understanding between the parties with respect to the subject matter hereof, and supersedes all prior written or oral agreements with respect to the subject matter hereof. This Agreement may not be modified except by written instrument signed by a duly authorized representative of each party. No failure, delay of forbearance of either party in exercising any power or right hereunder shall in any way restrict or diminish such party’s rights and powers under this Agreement, or operate as a waiver of any breach or nonperformance by either party of any terms of conditions hereof. If it shall be determined under any applicable law that a certain provision set forth in this Agreement is invalid or unenforceable, such determination shall not affect the remaining provisions of this Agreement. |
|--|-------|---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

|  | 12.3. | This Agreement may be assigned by BioLine. Executive may not assign or delegate her duties under this Agreement without the prior written consent of BioLine. This agreement shall be binding upon the heirs, successors and permitted assignees of Executive. The provisions of this Agreement shall survive the termination of the Employment Period and the assignment of this Agreement by BioLine to any successor or other assignee. |
|--|-------|--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

|  | 12.4. | The parties agree that this Agreement constitutes, among other things, notification in accordance with the Notice to Executives (Employment Terms) Law, 2002. |
|--|-------|---------------------------------------------------------------------------------------------------------------------------------------------------------------|

----

| BioLineRx Ltd. By:                                          Name:                                     Title:                                        | Ella Sorani                                              |
|---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

----

| 1.  | Name of Executive:                     | Ella Sorani                                                                                                      |
|-----|----------------------------------------|------------------------------------------------------------------------------------------------------------------|
| 2.  | ID No. of Executive                    | 313679219                                                                                                        |
| 3.  | Address of Executive:                  | 2 HaKinor Street, Kadima                                                                                         |
| 4.  | Position in BioLine:                   | Vice President, Development                                                                                      |
| 5.  | Commencement Date:                     | February 12, 2017                                                                                                |
| 6.  | Notice Period:                         | 30 days                                                                                                          |
| 7.  | Base Salary:                           | NIS 50,000                                                                                                       |
| 8.  | Equity Compensation                    | 100,000 stock options, subject to Board approval50,000 performance stock units (PSUs), subject to Board approval |
| 9.  | Bonus Plan                             | Up to six salaries annually, based on agreed performance criteria                                                |
| 10. | Vacation Days Per Year:                | 21                                                                                                               |
| 11. | Manager’s Insurance/Pension Fund | Yes                                                                                                              |
| 12. | Disability Insurance                   | Yes                                                                                                              |
| 13. | Advanced Study Fund                    | Yes                                                                                                              |
| 14. | Mobile Phone                           | Yes                                                                                                              |
| 15. | Computer                               | Yes                                                                                                              |
| 16. | Car                                    | Yes, senior manager level                                                                                        |

| ______________________ BioLine  | ______________________Executive |
|-------------------------------------------|---------------------------------|

----

| 1. | General. |
|----|----------|

|  | 1.1. | All capitalized terms herein shall have the meanings ascribed to them in the Employment Agreement to which this Exhibit B is attached (the “Employment Agreement”). For purposes of any undertaking of Executive toward BioLine, the term BioLine shall include all subsidiaries and affiliates of BioLine. |
|--|------|-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

|  | 1.2. | Executive’s obligations and representations and BioLine’s rights under this Exhibit B (this “Agreement”) shall apply as of the Commencement Date of the employment relationship between BioLine and Executive, and as of the first time in which Executive became engaged with BioLine, regardless of the date of execution of the Employment Agreement. |
|--|------|----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

|  | 1.3. | Executive’s undertakings hereunder shall remain in full force and effect after termination of this Agreement or the Employment Agreement, or any renewal thereof. |
|--|------|-------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

| 2. | Executive acknowledges that he/she has received or may receive information of a confidential and proprietary nature regarding the activities and business of BioLine, its subsidiaries or affiliates, all whether in oral, written, graphic, or machine-readable form, or in any other form, including, but not limited to, (i) patents and patent applications and related information, (ii) trade secrets and industrial secrets, and (iii) drugs, compounds, molecules, building blocks, chemical libraries, reaction protocols for chemical libraries, chemical structures, chemical design and model relationship data, chemical databases, assays, samples, media and other biological materials, procedures and formulations for producing any such materials, products, processes, ideas, know-how, trade secrets, drawings, inventions, improvements, formulas, equations, methods, developmental or experimental work, research or clinical data, discoveries, developments, designs, techniques, instruments, devices, computer software and hardware related to the current, future or proposed products and services, and including, without limitation, information regarding research, development, new service offerings or products, marketing and selling, business plans, forecasts, business methods, budgets, finances, licensing, collaboration and development arrangements, prices and costs, buying habits and practices, contact and mailing lists and databases, vendors, customers and clients, and potential business opportunities, and personnel (collectively, “Confidential Information”). Confidential Information may also include information furnished to BioLine by third parties, which, for purposes of this Agreement, shall all be deemed Confidential Information of BioLine. Notwithstanding the aforesaid, information that is in the public domain, through no act or omission of Executive shall not be deemed Confidential Information. The Confidential Information and all right, title and interest therein will remain at all times the exclusive property of BioLine (or any third party entrusting its own Confidential Information to BioLine). |
|----|--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

| 3. | At all times during the Employment Period and thereafter, Executive will hold all Confidential Information in strictest confidence and will not disclose, use, or make any copies thereof, unless required to by law or injunction. Executive hereby assigns to BioLine any rights that Executive may have or acquire in such Confidential Information and recognize that all Confidential Information shall be the sole property of BioLine and its assigns or licensors, as applicable. |
|----|-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

| 4. | Executive represents that he/she has assigned to BioLine all inventions, original works of authorship, developments, improvements, and trade secrets which were conceived, developed, made or reduced to practice by Executive prior to the date of the this Agreement or the Commencement Date, whichever is earlier (collectively referred to as “Prior Inventions”), in which Executive has or purports to have any ownership interest in or a license to use, and which relate to BioLine’s current or proposed business, products or research and development. Notwithstanding the foregoing, this Agreement will not be deemed to require assignment of any invention which was developed entirely on Executive’s own time without using BioLine’s equipment, supplies, facilities, or Proprietary Information and which is not related to the BioLine’s actual business, research or development. In addition, the Agreement will not apply with respect to inventions, if any, that were reduced to practice, made or conceived by Executive not in connection with Executive’s relationship with BioLine and have been fully disclosed to BioLine prior to Executive’s engagement with BioLine (“Excluded Inventions”).  All Excluded Inventions existing as of the date hereof are listed in Schedule 1 hereto. If, in the course of Executive’s employment, Executive incorporates an Excluded Invention into a product, process or machine of BioLine, BioLine is hereby granted and shall have a nonexclusive, royalty-free, irrevocable, perpetual, worldwide license (with rights to sublicense through multiple tiers of sublicenses) to make, have made, modify, use and sell such Excluded Invention.  Notwithstanding the foregoing, Executive agrees that: (i) Executive will not incorporate, or permit to be incorporated, Excluded Inventions in any Inventions of BioLine without the BioLine’s prior written consent, (ii) Executive’s failure to obtain such prior consent shall not affect the grant of the license relating to the Excluded Inventions as specified in this Section 4. |
|----|-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

----

| 5. | Executive will promptly disclose and describe to BioLine all inventions, improvements, designs, concepts, techniques, methods, processes, know how, and trade secrets, whether or not patentable, copyrightable or protectable as trade secrets that are made, developed, conceived or first reduced to practice or created by Executive, whether alone or jointly with others, during Executive’s employment with BioLine (i) which relate to BioLine’s business or actual or demonstrably anticipated research or development, (ii) which are developed in whole or in part on BioLine’s time or with the use of any of BioLine’s Confidential Information or other information, equipment, supplies, facilities or trade secret information, or (iii) which result directly or indirectly from any work performed by Executive for BioLine (the “Inventions,” and each an “Invention”). |
|----|--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

| 6. | Executive hereby assigns and agrees to assign in the future (when any such Inventions or Proprietary Rights (defined below) are first reduced to practice or first fixed in a tangible medium, as applicable) to BioLine or its designee(s) all of Executive’s right, title and interest in and to any and all Inventions (and all Proprietary Rights with respect thereto) whether or not patentable or registrable under copyright or similar statutes. Executive further specifically assigns to BioLine all original works of authorship, including any related moral rights, which are made by Executive (solely or jointly with others) during the Employment Period which are protectable by copyright pursuant to applicable copyright law. Executive also agrees to assign all of her right, title and interest in and to any particular Invention to any third party, including without limitation government agency, as directed by BioLine. Executive hereby waives and irrevocably quitclaims to BioLine any and all claims, of any nature whatsoever, that Executive now has or may hereafter have for infringement of any and all rights in Inventions and Proprietary Rights. To the extent any moral rights cannot be assigned under applicable law and to the extent the following is allowed by the laws in the various countries where moral rights exist, Executive hereby waives such moral rights and consent to any action of BioLine that would violate such moral rights in the absence of such consent. |
|----|------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

| 7. | Executive specifically acknowledges and agrees that Executive’s duties with BioLine will entail the invention and development of new ideas, technologies, products and other confidential and proprietary information, and that the creation of any such intellectual property is an inherent part of Executive’s duties with BioLine. Executive expressly agrees that the consideration paid to Executive pursuant to her Employment Agreement constitutes the sole consideration to which Executive may be entitled to for the assignment of any and all Inventions or Proprietary Rights made, developed, conceived or first reduced to practice or created by Executive (or with her assistance or contribution) including, without limitation, in accordance with Section 134 of the Patent Law, 5727-1967 (the “Patent Law”), and Executive shall not be entitled to receive any additional consideration in this respect whatsoever. Without derogating from the aforesaid, it is hereby clarified that the level of Executive’s compensation and consideration has been established based upon the aforementioned waiver of rights to receive any such additional royalties, consideration or other payments. The above will apply to any “Service Inventions” as defined in the Patent Law. It being clarified that under no circumstances will Executive be deemed to have any Proprietary Right in any Service Invention, notwithstanding the provision or non-provision of any notice of an invention or BioLine’s response to any such notice, under Section 132(b) of the Patent Law. This Agreement is expressly intended to be an agreement with regard to the terms and conditions of consideration for Service Inventions in accordance with Section 134 of the Patent Law. |
|----|-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

----

| 8. | Executive will assist BioLine in every proper way to obtain, and from time to time enforce, any Proprietary Rights relating to any Inventions in any and all countries.  To that end Executive will execute, verify and deliver such documents and perform such other acts (including appearances as a witness) as BioLine may reasonably request for use in applying for, obtaining, perfecting, evidencing, sustaining and enforcing such Proprietary Rights and the assignment thereof.  In addition, Executive will execute, verify and deliver assignments of such Proprietary Rights to BioLine or its designee.  Executive’s obligation to assist BioLine with respect to Proprietary Rights relating to any such Inventions in any and all countries shall continue indefinitely beyond termination of the Employment Period for any reason (the “Termination Date”), but BioLine shall compensate Executive at the rate of $350 per hour after the Termination Date for the time actually spent by Executive at BioLine’s request on such assistance. |
|----|-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

| 9. | If BioLine is unable for any reason, after reasonable effort, to secure Executive’s signature on any document needed in connection with the actions specified in the preceding paragraph, Executive hereby irrevocably designates and appoints BioLine and its duly authorized officers and agents as Executive’s agent and attorney in fact, which appointment is coupled with an interest, to act for and in Executive’s behalf to execute, verify and file any such documents and to do all other lawfully permitted acts to further the purposes of the preceding paragraph with the same legal force and effect as if executed by Executive. Executive hereby waives and holds BioLine harmless from any and all claims, of any nature whatsoever, which Executive now or may hereafter have for infringement of any Proprietary Rights assigned hereunder to BioLine. |
|----|-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

| 10. | Executive agrees to keep and maintain adequate and current records (in the form of notes, sketches, drawings and in any other form that may be required by BioLine) of all Confidential Information developed by Executive and all Inventions made by Executive during the Employment Period to BioLine, which records shall be available to and remain the sole property of BioLine at all times. |
|-----|----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

| 11. | During the Employment Period, Executive will not improperly use or disclose any confidential information or trade secrets, if any, of any former employer or any other person to whom Executive has an obligation of confidentiality, and Executive will not bring onto the premises of BioLine any unpublished documents or any property belonging to any former employer or any other person to whom Executive has an obligation of confidentiality unless consented to in writing by that former employer or person. |
|-----|-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

| 12. | Upon the earlier of (i) a written request by BioLine; or (ii) the expiration or termination of the employment, Executive shall promptly return to BioLine all Confidential Information, together with any and all copies or excerpts thereof and any and all other information directly or indirectly derived therefrom. Return or destruction of the Confidential Information as required hereunder shall not affect Executive’s remaining obligations pursuant to this Agreement. |
|-----|-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

----

| 13. | Non-Competition; Non-Solicitation. |
|-----|------------------------------------|

|  | 13.1. | In consideration of Executive’s terms of employment, which include special compensation for Executive’s undertakings under this Section 12, and in order to enable BioLine to effectively protect its Proprietary Information, Executive undertakes that during the Employment Period and for a period of twelve (12) months from the Termination Date, Executive will not directly or indirectly: (i) carry on or hold an interest in any company, venture, entity or other business (including, without limitation, as a shareholder other than a minority interest in a publicly traded company) which directly competes with the products or services of BioLine (a “Competing Business”) ; (ii) act as a consultant, employee or officer or in any managerial capacity in a Competing Business, or supply in direct competition with BioLine services to any person who, to Executive’s knowledge, was provided with services by BioLine any time during the twelve (12) months immediately prior to the Termination Date; (iii) solicit, canvass or approach or endeavor to solicit, canvass or approach any person who, to Executive’s knowledge, was provided with services by BioLine at any time during the twelve (12) months immediately prior to the Termination Date, for the purpose of offering services or products which directly compete with the services or products supplied by BioLine at the Termination Date; or (iv) employ, solicit or entice away or endeavor to solicit or entice away from BioLine any person employed by BioLine any time during the twelve (12) months immediately prior the Termination Date with a view to inducing that person to leave such employment and to act for another employer in the same or a similar capacity. |
|--|-------|-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

|  | 13.2. | Insofar as the protective covenants set forth in this Agreement are concerned, Executive specifically acknowledges, stipulates and agrees as follows: (i) the protective covenants are reasonable and necessary to protect the goodwill, property and Proprietary Information of BioLine, and the operations and business of BioLine; and (ii) the time duration of the protective covenants is reasonable and necessary to protect the goodwill and the operations and business of BioLine, and does not impose a greater restraint than is necessary to protect the goodwill or other business interests of BioLine. Nevertheless, if any of the restrictions set forth in this Agreement is found by a court having jurisdiction to be unreasonable or overly-broad as to geographic area, scope or time or to be otherwise unenforceable, the parties intend for the restrictions set forth in this Agreement to be reformed, modified and redefined by such court so as to be reasonable and enforceable and, as so modified by such court, to be fully enforced. |
|--|-------|------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

| 14. | Executive represents that Executive’s performance of all the terms of the Employment Agreement and this Agreement does not and will not breach any agreement to keep in confidence information acquired by Executive in confidence or in trust prior to Executive’s relationship with BioLine. Executive has not entered into, and agrees that he/she will not enter into, any agreement either written or oral in conflict herewith. |
|-----|---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

| 15. | Executive hereby consents that if Executive leaves the employ of BioLine, BioLine may notify any new employer of Executive’s rights and obligations under this Agreement. |
|-----|---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

| 16. | Executive acknowledges that any violation or threatened violation of this Agreement may cause irreparable injury to BioLine, entitling BioLine to seek injunctive relief in addition to all other legal remedies. |
|-----|-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

| 17. | Executive recognizes and agrees that: (i) this Agreement is necessary and essential to protect the business of BioLine and to realize and derive all the benefits, rights and expectations of conducting BioLine’s business; (ii) the area and duration of the protective covenants contained herein are in all things reasonable; and (iii) good and valuable consideration exists under the Employment Agreement, for Executive’s agreement to be bound by the provisions of this Agreement. |
|-----|------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

| 18. | The terms of paragraphs 13.1 through 13.3 of the Employment Agreement shall apply to this Agreement. |
|-----|------------------------------------------------------------------------------------------------------|

----

| 19. | EMPLOYEE ACKNOWLEDGES THAT HE/SHE HAS READ THIS AGREEMENT CAREFULLY, UNDERSTANDS ITS TERMS AND HAS BEEN GIVEN THE OPPORTUNITY TO DISCUSS IT WITH INDEPENDENT LEGAL COUNSEL. |
|-----|-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

----

----

| · | honest and ethical conduct by all of the Company’s employees, officers and directors, including the ethical handling by such persons of actual or apparent conflicts of interest between personal and professional relationships; |
|--------|-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

| · | full, fair, accurate, timely and understandable disclosure in the reports and documents the Company files with, or submits to, the U.S. Securities and Exchange Commission (“SEC”) or the Israeli Securities Authority (“ISA”), and in other public communications made by the Company; |
|--------|-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

| · | compliance with applicable governmental laws, rules and regulations; |
|--------|----------------------------------------------------------------------|

| · | the prompt internal reporting to the appropriate person of violations of this Code; and |
|--------|-----------------------------------------------------------------------------------------|

| · | Accountability for adherence to this Code. |
|--------|--------------------------------------------|

----

| •  | Is the course of conduct legal? |
|---------------|---------------------------------|

| • | Is the course of conduct in accordance with the guidelines set forth in this Code and with Company policies and procedures? |
|---------|-----------------------------------------------------------------------------------------------------------------------------|

| • | Would you or the Company be compromised or embarrassed if the situation were known by your co-workers or the public? |
|---------|----------------------------------------------------------------------------------------------------------------------|

| •  | Does the intended course of conduct have the appearance of impropriety? |
|---------------|-------------------------------------------------------------------------|

| Nurit BenjaminiAudit Committee Chairpersonemail: nurit378@gmail.comTel: 052-644-0745 | Linur Dloomy, CPA (Deloitte)Internal Auditore-mail: LDloomy@deloitte.co.ilTel: 052-583-9635 |
|--------------------------------------------------------------------------------------|---------------------------------------------------------------------------------------------|

----

----

----

----

----

----

|  | · | to educate all Company personnel; |
|--|--------|-----------------------------------|

|  | · | to set forth guidelines for courses of action; |
|--|--------|------------------------------------------------|

|  | · | to protect the Company and all of its personnel against legal liability; and |
|--|--------|------------------------------------------------------------------------------|

|  | · | to preserve the reputation of the Company and its personnel for integrity and ethical conduct. |
|--|--------|------------------------------------------------------------------------------------------------|

|  | · | a civil penalty of up to three times the profit gained or loss avoided; |
|--|--------|-------------------------------------------------------------------------|

|  | · | a criminal fine (no matter how small the profit) of up to $5 million; and |
|--|--------|---------------------------------------------------------------------------|

|  | · | a jail term of up to twenty years. |
|--|--------|------------------------------------|

----

|  | · | a civil penalty of the greater of $1 million or three times the profit gained or loss avoided as a result of the employee’s violation; and |
|--|--------|--------------------------------------------------------------------------------------------------------------------------------------------------|

|  | · | a criminal penalty of up to $25 million. |
|--|--------|------------------------------------------|

|  | · | is not generally known to the public, and |
|--|--------|-------------------------------------------|

|  | · | which, if publicly known, would likely affect either the market price of the Company’s securities or a person’s decision to buy, sell or hold the Company’s securities. |
|--|--------|-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

|  | · | quarterly or annual earnings results; |
|--|--------|---------------------------------------|

|  | · | projections of future results or sales; |
|--|--------|-----------------------------------------|

|  | · | earnings or losses; |
|--|--------|---------------------|

|  | · | news of a pending or proposed merger, acquisition or tender offer; |
|--|--------|--------------------------------------------------------------------|

|  | · | an important financing transaction; |
|--|--------|-------------------------------------|

----

|  | · | significant clinical or regulatory developments; |
|--|--------|--------------------------------------------------|

|  | · | the entry into or termination of a significant collaboration, joint venture or strategic alliance; |
|--|--------|----------------------------------------------------------------------------------------------------|

|  | · | changes in management; |
|--|--------|------------------------|

|  | · | significant new products or discoveries; |
|--|--------|------------------------------------------|

|  | · | plans regarding strategy or significant capital investments; |
|--|--------|--------------------------------------------------------------|

|  | · | impending bankruptcy or financial liquidity problems; |
|--|--------|-------------------------------------------------------|

|  | · | criminal charge or government investigations; |
|--|--------|-----------------------------------------------|

|  | · | internal financial information which departs from what the market would expect; and |
|--|--------|-------------------------------------------------------------------------------------|

|  | · | the gain or loss of any significant contract or agreement. |
|--|--------|------------------------------------------------------------|

----

|  | · | Trading in the Company’s securities on a short-term basis.  Any ordinary shares of the Company purchased in the open market should be held for a minimum of 60 days. |
|--|--------|--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

|  | · | Short sales of the Company’s securities. |
|--|--------|------------------------------------------------|

|  | · | Use of the Company’s securities to secure a margin or other loan, except in limited cases with the prior approval of the Policy Administrator. |
|--|--------|------------------------------------------------------------------------------------------------------------------------------------------------------|

|  | · | Transactions in straddles, collars, or other similar risk reduction devices, except in limited cases with the prior approval of the Policy Administrator. |
|--|--------|-----------------------------------------------------------------------------------------------------------------------------------------------------------|

|  | · | Transactions in publicly-traded options relating to the Company’s securities (i.e., options that are not granted by the Company), except in limited cases with the prior approval of the Policy Administrator. |
|--|--------|----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

----

|  | · | the periods starting on the 15th day after the close of each fiscal quarter and ending at the beginning of the second business day after the release of the Company’s financial results for each quarter and, in the case of the fourth quarter, financial results for the year end; and |
|--|--------|------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

|  | · | any other periods as determined by the Company. You will be notified by e-mail when you may not trade in the Company’s securities during such periods, and you will also be notified when trading restrictions are lifted. |
|--|--------|----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

----

| Date: __________________________ | Signature ________________________ Name: ____________________________                  (Please Print) |
|----------------------------------|------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

----

----

| 1. | Contents |
|----|----------|

| 2.  | Senior officer declaration |
|----------|----------------------------|

| 3.  | General information on an administrative enforcement plan |
|----------|-----------------------------------------------------------|

| 4.  | Organizational structure and division of functions and responsibility |
|----------|-----------------------------------------------------------------------|

| 5.  | Guiding principles/issues addressed |
|----------|-------------------------------------|

| 6.  | Appointment of an internal enforcement officer |
|----------|------------------------------------------------|

| 7.  | Contact and reporting |
|----------|-----------------------|

| 8.  | Sanctions in events of violations and failure to report |
|----------|---------------------------------------------------------|

| 9.  | Findings of mapping of the existing situation |
|----------|-----------------------------------------------|

| 10.  | Relevant procedures |
|-----------|---------------------|

| 11.  | Assimilation plan |
|-----------|-------------------|

| 12.  | Annex A |
|-----------|---------|

----

| 2. | Senior officer declaration |
|----|----------------------------|

| 2.1 | CEO’s message |
|-----|---------------------|

----

| 3. | General information on an administrative enforcement plan |
|----|-----------------------------------------------------------|

| 3.1 | Improvement of Internal Enforcement Proceedings in the ISA Law, 5770-2010 |
|-----|---------------------------------------------------------------------------|

|   | (a) | “The CEO of the corporation and a partner other than a limited partner, are obligated to supervise and institute any and all reasonable means under the circumstances of the case to prevent the commission of a violation by the corporation or partnership, as the case may be, or by any of their employees.”                                                                                                                                                                                                      |
|--------|-----|-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
|   | (b) | If a violation is committed the presumption is that the CEO of the corporation or a partner other than a limited partner in the partnership, as the case may be, has breached his obligation pursuant to Subsection (a) and may be subject to one or more of the means of enforcement as specified below...unless he proves that he has fulfilled his obligation pursuant to Subsection (a):                                                                                                                                  |
|   | (c) | If the corporation has established adequate procedures to prevent a violation as provided in Subsection (b), appointed an officer on its behalf to supervise the compliance therewith, including with regard to providing guidance to the corporation’s employees for the compliance therewith, and instituted reasonable steps to remedy the violation and prevent the recurrence thereof, the presumption is that the CEO or the partner, as the case may be, has fulfilled his obligation as provided in Subsection (a). |

| 3.2 | What is an enforcement plan |
|-----|-----------------------------|

----

| 3.3 | Objectives of an enforcement plan |
|-----|-----------------------------------|

| ü | Minimization of the possibility of the occurrence of a violation |
|--------|------------------------------------------------------------------|

| ü | Immediate effect on the examining entity in the event that a violation occurs |
|--------|-------------------------------------------------------------------------------|

| 3.4 | Applicability of the enforcement plan |
|-----|---------------------------------------|

| 3.5 | Prohibition on insurance and indemnification |
|-----|----------------------------------------------|

| 3.6 | Documentation and provision of documents for inspection and storing of documents |
|-----|----------------------------------------------------------------------------------|

| 4. | Organizational structure and division of functions and responsibility |
|----|-----------------------------------------------------------------------|

| 4.1 | Organizational structure for the issue of administrative enforcement (areas of responsibility, reporting chain, decision making, etc.) |
|-----|----------------------------------------------------------------------------------------------------------------------------------------|

----

|  | 4.1.1 | Responsibility of the Board of Directors and its committees |
|--|-------|-------------------------------------------------------------|

|  | 4.1.1.1 | Formulation and adoption of the Company’s internal enforcement plan |
|--|---------|---------------------------------------------------------------------------|

|  | 1. | Special-purpose meetings for the presentation of the subject. |
|--|----|---------------------------------------------------------------|

|  | 2. | Presentation, discussion and approval of the outline of the enforcement plan project. |
|--|----|---------------------------------------------------------------------------------------|

|  | 3. | Presentation of the findings of the mapping of the existing situation (compliance survey) and deliberation on the recommendations deriving therefrom. |
|--|----|-------------------------------------------------------------------------------------------------------------------------------------------------------|

|  | 4. | Presentation, discussion and approval of the procedures comprising the internal enforcement plan. |
|--|----|---------------------------------------------------------------------------------------------------|

|  | 5. | Approval of the final plan. |
|--|----|-----------------------------|

|  | · | Setting the enforcement plan into motion |
|--|--------|------------------------------------------|

|  | · | Mapping of the existing situation |
|--|--------|-----------------------------------|

|  | · | Formulation of the plan and its procedures |
|--|--------|--------------------------------------------|

|  | · | Formulation of the assimilation plan |
|--|--------|--------------------------------------|

|  | · | Ongoing monitoring |
|--|--------|--------------------|

|  | 4.1.1.2 | Implementation of the plan |
|--|---------|----------------------------|

|  | 4.1.1.3 | Supervision of the enforcement plan |
|--|---------|-------------------------------------|

|  | 4.1.1.4 | Handling violations of the enforcement proceedings |
|--|---------|----------------------------------------------------|

----

|  | 4.1.1.5 | Reporting to the Board of Directors and the Audit Committee |
|--|---------|-------------------------------------------------------------|

|  | 4.1.2 | Responsibility of the CEO/management – steering committee |
|--|-------|-----------------------------------------------------------------|

|  | 4.1.3 | Responsibility of the Chief Financial & Operating Officer |
|--|-------|---------------------------------------------------------------|

|  | 4.1.4 | Responsibility of the General Counsel and Internal Enforcement Officer |
|--|-------|------------------------------------------------------------------------|

----

|  | 4.1.5 | Internal auditor’s responsibility |
|--|-------|-----------------------------------------|

----

| 5. | Guiding principles/issues addressed |
|----|-------------------------------------|

| 5.1 | Prospectus/annual report process |
|-----|----------------------------------|

| 5.2 | Reports to the SEC and ISA |
|-----|----------------------------|

----

| 5.3 | Prohibition on the use of inside information |
|-----|----------------------------------------------|

| 5.4 | Transactions with interested parties |
|-----|--------------------------------------|

| 5.5 | Procedure for period end closing |
|-----|----------------------------------|

----

| 6. | Appointment of an Internal Enforcement Officer |
|----|------------------------------------------------|

| 6.1 | Appointment of an Officer |
|-----|---------------------------|

| 6.2 | The appointment and approval (and change) process |
|-----|---------------------------------------------------|

| 6.3 | Powers |
|-----|--------|

|  | 6.3.1 | Ongoing supervision: |
|--|-------|----------------------|

|  | 6.3.2 | Investigating suspected violations: |
|--|-------|-------------------------------------|

|  | 6.3.3 | Remedying the violation: |
|--|-------|--------------------------|

|  | 6.3.4 | Reporting the violation: |
|--|-------|--------------------------|

----

----

|  | 6.3.5 | Preventing the recurrence of the violation |
|--|-------|--------------------------------------------|

| 6.4 | Supervision over the Officer |
|-----|------------------------------|

| 6.5 | Officer’s reporting responsibility |
|-----|------------------------------------------|

| 7. | Contact and reporting |
|----|-----------------------|

| 7.1 | Possibilities of contact and reporting in the event of a suspected violation |
|-----|------------------------------------------------------------------------------|

----

|  | a. | Employees, officers and directors |
|--|----|-----------------------------------|

|   | Internal Auditor, Linur Dloomy, CPA | Audit Committee Chairperson, Nurit Binyamini |
|--------|-------------------------------------|----------------------------------------------|
|   |                                |                                         |
|   | E-mail: ldloomy@deloitte.co.il      | E-mail: Nurit378@gmail.com                   |
|   |                                |                                         |
|   | Tel. 052-5838635                    | 052-6440745                                  |

|  | b. | Service providers |
|--|----|-------------------|

| 7.2 | [intentionally omitted] |
|-----|-------------------------|

| 7.3 | External reporting |
|-----|--------------------|

----

| 8. | Sanctions in events of violation and failure to report |
|----|--------------------------------------------------------|

| 8.1 | Determination of sanctions in events of violation |
|-----|---------------------------------------------------|

| 9. | Findings of a mapping of the existing situation |
|----|-------------------------------------------------|

| 10. | Relevant procedures |
|-----|---------------------|

| 10.1 | Statement of Company Policy – Securities Trades by BioLineRx Ltd. personnel |
|------|-----------------------------------------------------------------------------------|

| 10.2 | Transactions involving interested and related parties |
|------|-------------------------------------------------------|

| 10.3 | Procedure for prospectus/annual report/other reports to the SEC and ISA (Disclosure Controls) |
|------|-----------------------------------------------------------------------------------------------|

| 10.4 | Period end closing procedure |
|------|------------------------------|

----

| 11. | Assimilation plan |
|-----|-------------------|

| From the ISA Document: Measures shall be taken in order to ensure the commitment of all echelons of the corporation to the aforesaid procedures, for example, through the establishment of such commitment in the disciplinary code or employment agreements. |
|--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

----

|  | a. | Frontal training sessions shall be held by the Officer on behalf of the Company or by an outside body. The training sessions shall be performed at least once a year. The training sessions shall include a review of the enforcement plan, possible violations and reporting methods. |
|--|----|----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

|  | b. | Written training sessions. At least once a year the Officer shall send a presentation via e-mail to the employees that will include an employee guide – a review of the enforcement plan, possible violations and reporting methods. The employee shall be required to send a return e-mail to the Officer in which he confirms that he has read the content of the guide and undertakes to act according thereto. |
|--|----|--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

----

----

----

| 1. | BioLine shall provide Employee with the use of a vehicle selected by BioLine. BioLine shall have the sole discretion to determine the type of vehicle provided to Employee in accordance with the then current BioLine car policy. The vehicle, a detailed description of which appears in Exhibit A hereto (the “Vehicle”), will be provided to Employee no later than Click here to enter text. (the “Effective Date”) and for a period of up to thirty-six (36) months from the calendar month following the Effective Date (the “Term”). Upon receipt of the Vehicle, Employee shall execute the Vehicle Receipt Form attached as Exhibit B hereto. Notwithstanding the abovementioned, the Vehicle provided to Employee may have been leased to BioLine prior to the date hereof, in which event, the Term shall be amended accordingly, and this Agreement shall apply to the applicable Term. If Employee receives a vehicle for the interim period before the Effective Date (the “Temporary Vehicle”), the terms of this Agreement shall apply to the Temporary Vehicle in full. It is clarified, however, that the interim period shall not be considered part of the Term. |
|----|--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

| 2. | Payments by Employee |
|----|----------------------|

|  | 2.1. | Employee acknowledges that the benefit he/she receives from the Vehicle is taxable, and agrees to bear all taxes arising out of the use of the Vehicle (“Vehicle Taxes”). Employee acknowledges that Vehicle Taxes will be withheld from his/her salary as required by law. |
|--|------|-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

|  | 2.2. | Vehicle Taxes may be increased according to changes from time to time in the applicable tax regulations, and Employee’s Salary will be reduced accordingly in the event of such regulatory changes. |
|--|------|-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

|  | 2.3. | Employee shall be responsible for the following payments: |
|--|------|-----------------------------------------------------------|

|   | 2.3.1. | Fines and penalty payments including parking tickets and costs related to the imposing of a prohibited use notice (השבתה מינהלית); |
|--------|--------|------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

|   | 2.3.2. | Fuel over the monthly limit specified in Exhibit A, as may be amended from time to time due to changes in the prices of fuel (the “Fuel Limit”). Employee will be charged once every six (6) months for use of fuel over the Fuel Limit, which will be calculated in accordance with Employee’s average use during the preceding six-month period (e.g., if Employee’s Fuel Limit is 1000 liters, and Employee’s average monthly use is 1100 liters, Employee will be charged for 600 liters (excess use of 100 multiplied by six months)); |
|--------|--------|---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

|   | 2.3.3. | Fines imposed by the leasing company for mileage costs exceeding the annual limit specified in Exhibit A, as may be amended from time to time based on Employee’s place of residence (the “Mileage Limit”); |
|--------|--------|-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

|   | 2.3.4. | Highway 6 expenses (פסקל) and tolls, except for tolls related to business use, as set forth in Section 3.1 below; |
|--------|--------|-------------------------------------------------------------------------------------------------------------------------------------------|

----

|   | 2.3.5. | Tel Aviv Fast Lane expenses, except for tolls related to business use, as set forth in Section 3.1 below; |
|--------|--------|-----------------------------------------------------------------------------------------------------------|

|   | 2.3.6. | Fines and expenses imposed by the leasing company for tolls related to travel on Highway 6 or the Tel Aviv Fast Lane that is not based on subscriptions arranged by Employee; |
|--------|--------|-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

|   | 2.3.7. | Insurance deductible, which will be borne by Employee if the damage was caused by Employee, as follows: |
|--------|--------|---------------------------------------------------------------------------------------------------------|

|  | a. | On the third occurrence of any such damage, Employee shall bear 30% of the insurance deductible. |
|--|----|--------------------------------------------------------------------------------------------------|

|  | b. | From the fourth occurrence of any such damage and onwards, Employee shall bear 50% of the insurance deductible. |
|--|----|-----------------------------------------------------------------------------------------------------------------|

|  | c. | Employee will be charged as provided above only if damage was reported to the leasing company in a timely manner. If damage was not reported in a timely manner, and as a result the leasing company charges BioLine for additional events of damage, Employee will bear the full cost of the insurance deductible. |
|--|----|---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

|   | 2.3.8. | Employee shall bear the cost of any flat tires, except for the first two (2) flat tires per year, as indicated in Section 3.1.1 below; and |
|--------|--------|--------------------------------------------------------------------------------------------------------------------------------------------|

|   | 2.3.9. | It is Employee’s responsibility to ensure that the Vehicle has a full tank upon sending the Vehicle to maintenance and repairs. If the Vehicle’s tank is not full, and an extra charge is billed for fuel, Employee shall bear the extra fuel charge, provided however that BioLine may decide in its sole discretion to bear such expense if Employee could not have predicted the repair. |
|--------|--------|---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

|  | 2.4. | Employee undertakes to pay, upon first demand, all fines and penalty payments, such as parking tickets, etc., within sixty (60) days of receipt of the ticket. If Employee does not pay the required fines, etc., BioLine may withhold such amount from his/her Salary, together with any late penalties or additional payments which may be assessed. |
|--|------|--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

|  | 2.5. | Employee confirms and represents that he/she is the holder of the Vehicle as of the Effective Date. Consequently, Employee hereby agrees to the assignment of any tickets, fines, penalties, as well as traffic points (נקודות) to Employee, and authorizes BioLine to carry out such assignment vis-a-vis the competent authority if required. Employee has executed the Confirmation and Assignment deed attached as Exhibit C hereto. |
|--|------|------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

| 3. | Payments by BioLine |
|----|---------------------|

|  | 3.1. | BioLine shall pay or be responsible for the payment of the monthly leasing payment charged by the leasing company for the Vehicle (the “Lease Payment”), and for expenses related to the Vehicle, as follows: |
|--|------|---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

|   | 3.1.1. | Insurance, licensing fees, maintenance and repairs, and the repair cost of two (2) flat tires a year, in accordance with BioLine’s car policy; |
|--------|--------|------------------------------------------------------------------------------------------------------------------------------------------------------|

|   | 3.1.2. | Insurance deductible of 100% if the damage is caused by a third party, and the following portions of the insurance deductible if the damage is caused by Employee: |
|--------|--------|--------------------------------------------------------------------------------------------------------------------------------------------------------------------|

|  | a. | 100% of the insurance deductible in the first two occurrences; |
|--|----|----------------------------------------------------------------|

|  | b. | 70% of the insurance deductible in the third occurrence; |
|--|----|----------------------------------------------------------|

|  | c. | 50% of the insurance deductible in the fourth occurrence and onwards. |
|--|----|-----------------------------------------------------------------------|

|   | 3.1.3. | Fuel up to the Fuel Limit; |
|--------|--------|----------------------------|

----

|   | 3.1.4. | Mileage costs up to the Mileage Limit; |
|--------|--------|----------------------------------------|

|   | 3.1.5. | Reimbursement for Highway 6 tolls in connection with business related travel only, and subject to the installation by Employee of the Highway 6 meter (פסקל), in accordance with BioLine’s procedures for reimbursement of expenses; |
|--------|--------|--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

|   | 3.1.6. | Reimbursement for Tel Aviv Fast Lane tolls in connection with business related travel only, and subject to Employee’s arranging a subscription; and |
|--------|--------|-----------------------------------------------------------------------------------------------------------------------------------------------------------|

|   | 3.1.7. | Other expenses, all as may be decided from time to time by BioLine and in accordance with BioLine’s car policy then in effect. |
|--------|--------|--------------------------------------------------------------------------------------------------------------------------------------|

|  | 3.2. | For the avoidance of doubt, BioLine shall not be responsible for the payment of any fines, penalties or other expenses as set forth in Section 2.3 above. |
|--|------|-----------------------------------------------------------------------------------------------------------------------------------------------------------|

| 4. | Operation and Use of the Vehicle |
|----|----------------------------------|

|  | 4.1. | The Vehicle shall be the exclusive responsibility of Employee. Employee shall execute the Undertaking to Secure the Vehicle and Security Code in the form attached as Exhibit D hereto. |
|--|------|-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

|  | 4.2. | Employee undertakes to abide by any and all laws and regulations regarding the use of the Vehicle and to operate the vehicle in a cautious manner. Employee further undertakes to notify BioLine immediately if Employee’s license is revoked for any reason. Employee will take all appropriate measures to avoid loss of or damage to the Vehicle or to any third party, and shall at all times comply with the then current BioLine car policy. Employee also undertakes to follow any other limitation or requirement set by the terms of the Vehicle’s insurance policy. |
|--|------|-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

|  | 4.3. | Employee undertakes not to (a) transport more passengers or weight than are allowed by the insurance policy, (b) use the Vehicle for any purpose other than for work-related travel or for his/her own personal needs, (c) drive the Vehicle on unpaved roads or in places which are inappropriate for travel by a private vehicle, (d) take or drive the Vehicle to any areas which are outside the area of the State of Israel (including the Sinai Peninsula and the area of the Palestinian Authority), (e) use the Vehicle for towing, for pushing another vehicle or any other object, for competition, for racing, for testing stability or speed or for any other motor sport, (f) use the Vehicle for any illegal use, political purpose or in connection with any organization, strike or riot, or (g) leave the keys in the Vehicle while Employee is not in the Vehicle, or leave the Vehicle without activating the locking mechanism or other means of securing the Vehicle, even for a short time. |
|--|------|-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

|  | 4.4. | Employee will bear the cost of any expense or damage to the Vehicle or to a third party (a) arising from any breach of the terms and conditions of this Agreement or from negligent use of the Vehicle, or (b) for which the insurance policy does not compensate BioLine. In addition, if a prohibited use notice (השבתה מינהלית) is imposed on the Vehicle, Employee shall fully cooperate with BioLine in order to release the Vehicle from impound, and shall not be entitled to receive a temporary vehicle during such period. Employee shall indemnify and hold BioLine harmless from any third party claims relating to the prohibited use notice (השבתה מינהלית), and will indemnify BioLine for any damages to the Vehicle, or any other damages which BioLine shall incur in connection thereof. |
|--|------|-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

|  | 4.5. | The persons who are authorized to drive the Vehicle in addition to Employee are the members of Employee’s immediate family (spouse and Employee’s children) or Employee’s ‘significant other’, for reasonable family use only; provided that each such driver must hold a valid drivers’ license. Notwithstanding the foregoing, Employee must request BioLine’s explicit consent with respect to any driver who is over the age of 75 or under the age of 23, or any driver who has not held a valid driver’s license for at least two years. Without BioLine’s written consent, the drivers specified in the preceding sentence are not authorized to drive the Vehicle and will not be covered by the insurance policy.  All the terms set forth in this Agreement are deemed to be accepted by all persons who drive the Vehicle. |
|--|------|-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

----

| 5. | Care and Treatment of the Vehicle |
|----|-----------------------------------|

|  | 5.1. | Employee shall treat the Vehicle as if it was his/her own and shall ensure that the Vehicle remains in good condition. |
|--|------|------------------------------------------------------------------------------------------------------------------------|

|  | 5.2. | Employee will notify BioLine and the police if the Vehicle is stolen as soon as he/she becomes aware of the theft. |
|--|------|--------------------------------------------------------------------------------------------------------------------|

|  | 5.3. | Employee will notify BioLine or the person nominated by it of any damage or malfunction of the Vehicle, as soon as he/she becomes aware of the damage or malfunction, and will ensure that any required repairs are made. Employee will also notify BioLine or the person nominated by it of the regularly scheduled maintenance dates of the vehicle.  All care, maintenance and repairs to the Vehicle will be made only by the leasing company at its expense, unless Employee is specifically notified otherwise. |
|--|------|---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

|  | 5.4. | Employee acknowledges that he/she may not make any alterations to the Vehicle’s interior or exterior, nor install any accessories in the Vehicle, including, without limitation, a car stereo or cellular speakerphone (דיבורית) without the prior written consent of BioLine. The cost of installing a cellular speakerphone shall be borne by BioLine, provided however that Employee is responsible for making the necessary arrangements for the installation of the cellular speakerphone. In addition, Employee acknowledges and undertakes not to add any sticker, sign or other visible notice on the Vehicle, whether including political statements or otherwise. Employee acknowledges that BioLine may, at its discretion require that the Vehicle bear BioLine’s logo. |
|--|------|-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

|  | 5.5. | If an electronic device for measurement of gas (פזומט) is installed, Employee shall, to the extent possible, refuel only in the gas stations supporting the device. |
|--|------|---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

|  | 5.6. | In the event of an accident, Employee: (a) will immediately notify both BioLine and the leasing company and will forward to them details of the accident in writing; (b) will immediately notify the police and other authorities, to the extent required by law; (c) will not admit or confess to any guilt or responsibility therefor or provide any information not required by law, nor will accept or propose any offers, payments, arrangements or any other obligations in connection with the accident; (d) will file an accident report provided by BioLine and will include all details including the names, addresses, licenses and insurers of all the parties involved, and the license plate numbers of all of the vehicles involved, whether or not any damage was caused to the Vehicle, (e) will not leave the Vehicle at the scene without appropriate cautionary measures, and (f) will notify BioLine and the leasing company of any summons received to appear before a court. |
|--|------|-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

|  | 5.7. | In the event of a flat tire, Employee (i) shall change the tire to the spare tire, and notify BioLine, in according with BioLine’s car policy; (ii) shall be responsible to repair the flat tire as soon as possible, and in no event after traveling more than eighty (80) Kilometers with the spare tire, due to safety restrictions, and if a new tire is required, Employee shall obtain the approval of the HR department prior to the purchase of a new tire. Employee will be reimbursed for the repair in accordance with BioLine’s procedures for reimbursement of expenses. |
|--|------|---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

| 6. | Return of the Vehicle |
|----|-----------------------|

|  | 6.1. | Upon the termination of his/her employment with BioLine for any reason, Employee shall return the Vehicle to BioLine in working order and in good condition, subject only to wear and tear resulting from careful and reasonable use of the Vehicle. Employee shall return the Vehicle together with the car keys and any duplicates thereof provided to Employee, licenses and all other documents, and the Vehicle shall empty and without any object whatsoever belonging to Employee. |
|--|------|-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

----

|  | 6.2. | It is hereby clarified, that in no event shall Employee place a lien on the Vehicle (in connection with any alleged debt or obligation of BioLine towards Employee, or for any other reason). |
|--|------|-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

|  | 6.3. | If, prior to the expiration of the Term, Employee voluntarily terminates his/her employment or BioLine terminates Employee’s employment for Cause (as such term is defined in the Employment Agreement), Employee shall reimburse BioLine for any charges or penalties BioLine may suffer due to the early termination of the lease for the Vehicle; provided, however, that the amount of such penalty shall not exceed (i) the Lease Payment multiplied by three (3) in the event of termination prior to the first anniversary of the Effective Date, (ii) the Lease Payment multiplied by two (2) in the event of termination following the first anniversary of the Effective Date, and prior to the second anniversary of the Effective Date, and (iii) one Lease Payment in the event of termination following the second anniversary of the Effective Date, and prior to the third anniversary of the Effective Date. Such funds will be withheld from Employee’s salary. |
|--|------|-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

|  | 6.4. | Employee shall not be entitled to use a Company Car during unpaid leaves or absences, unless specifically approved by BioLine in writing. |
|--|------|-------------------------------------------------------------------------------------------------------------------------------------------|

| 7. | General |
|----|---------|

|  | 7.1. | Employee confirms that he/she understands that any breach of or deviation from the terms of this Agreement will cause insurance coverage to be denied, and that any damage caused by such breach or deviation will be borne by Employee personally. |
|--|------|-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

|  | 7.2. | Employee confirms and acknowledges that Employee’s obligations hereunder shall apply to any replacement vehicle provided to Employee. |
|--|------|---------------------------------------------------------------------------------------------------------------------------------------------|

|  | 7.3. | Employee acknowledges and agrees that the procedures set forth herein may be changed from time to time by BioLine, in its sole discretion. |
|--|------|--------------------------------------------------------------------------------------------------------------------------------------------|

|  | 7.4. | For the avoidance of doubt, nothing herein shall obligate BioLine to employ Employee or to continue Employee’s employment with BioLine, or derogate in any way from BioLine’s right to terminate Employee’s employment. |
|--|------|-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

|  | 7.5. | This Agreement constitutes the entire agreement and understanding between the parties with respect to the subject matter hereof, and supersedes all prior written or oral agreements with respect thereto. This Agreement may be assigned by BioLine; Employee may not assign this Agreement. |
|--|------|-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

| ________________________BioLineRx Ltd.By: Philip SerlinTitle: Chief Financial and Operating Officer | ________________________EmployeeName:Date: |
|-----------------------------------------------------------------------------------------------------|--------------------------------------------|

----

----

|  | 1. | Valid License; |
|--|----|----------------|

|  | 2. | Valid Insurance Certificate; |
|--|----|------------------------------|

|  | 3. | Vehicle Manual; |
|--|----|-----------------|

|  | 4. | Maintenance Manual; |
|--|----|---------------------|

|  | 5. | Car Jack; |
|--|----|-----------|

|  | 6. | Tire Wrench; |
|--|----|--------------|

|  | 7. | Spare Tire; |
|--|----|-------------|

|  | 8. | Car Key + other Security Measures; |
|--|----|------------------------------------|

|  | 9. | Triangle Warning Sign; |
|--|----|------------------------|

|  | 10. | Dustbin; and |
|--|-----|--------------|

|  | 11. | Sound System (Radio and Disk). |
|--|-----|--------------------------------|

----

----

| 1. | I the undersigned, Click here to enter text., I.D. no. Click here to enter text., hereby confirm and undertake to BioLine that I and/or any other driver on my behalf authorized to drive the vehicle, model type Click here to enter text., vehicle number Click here to enter text., shall follow all of the instructions below: |
|----|------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

|  | · | I will not leave the vehicle without activating the installed security measures; |
|--|--------|----------------------------------------------------------------------------------|

|  | · | I will not leave the vehicle with the keys inside the vehicle; |
|--|--------|----------------------------------------------------------------|

|  | · | I will not abandon the car keys; |
|--|--------|----------------------------------|

|  | · | I will not keep the vehicle’s coded immobilizer number and/or any other security measures, if such are installed, in proximity to the keys; |
|--|--------|---------------------------------------------------------------------------------------------------------------------------------------------------|

|  | · | I will not leave the security code, if such is installed, inside the vehicle or in its proximity; |
|--|--------|---------------------------------------------------------------------------------------------------|

|  | · | I will not leave a written copy of the security code, if such is installed, in an exposed place in the vehicle; and |
|--|--------|---------------------------------------------------------------------------------------------------------------------|

|  | · | I will watch over the vehicle while taking all reasonable precautions to avoid loss and/or theft of the vehicle. |
|--|--------|------------------------------------------------------------------------------------------------------------------|

| 2. | I hereby confirm that should I act contrary to the foregoing instructions or should I breach any of my obligations to safeguard the vehicle as a reasonable and cautious owner safeguards his own property, I will bear all damage expenses and/or loss caused to BioLine as a result of any action and/or failure to act by me/us, without any condition or restriction. |
|----|---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

| 3. | For the avoidance of doubt it is hereby clarified that my signature below, confirming my obligation in accordance with this document, will take precedence over any agreement and/or representation and/or understanding, if there were such, prior to this date. |
|----|-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

----